Dongxing Zha

Company: Alloy Therapeutics

Job title: CTO

Seminars:

Increasing Target Specificity & Tackling Intracellular Targets for TCRm-based Therapeutics Development with Keyway’s TCRm Discovery Offering 2:30 pm

Discussing the major challenges to the discovery of TCRm and TCR-based therapeutics against intracellular protein targets Sharing Keyway’s TCR mimic discovery offering, which comprises industry-leading solutions, including high-quality pMHC complex antigen production capabilities and proprietary specificity screening Presenting a study case featuring the discovery campaign that yielded highly specific, functional TCRm binders against an intracellular…Read more

day: Conference Day One